investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
Yves Pommier
4 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michael Stratton
Wellcome Trust (WT)
London, United Kingdom
Matthew Garnett
Wellcome Trust (WT)
London, United Kingdom
Shunichi Takeda
Kyoto University
Kyoto, Japan
Manel Esteller
Institut d'Investigació Biomédica de Bellvitge
Barcelona, Spain
Yves Pommier
National Cancer Institute (NIH)
Rockville, United States
Related projects
Ajit P Varki
Oligosaccharies of Normal and Malignant Cells
Colorectum
Craig B Thompson
Role of IDH Mutations in Acute Myeloid Malignancies
Leukaemia
Charalampos Kalodimos
Mechanisms of autoinhibition and activation of the Abl kinase
Leukaemia
Hiroaki Mitsuya
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors
All cancers but non-melanoma skin cancer
Andrew Gregory Sikora
TARGETING INOS TO INHIBIT MYELOID-DERIVED SUPPRESSOR CELLS (MDSC) IN MELANOMA
All cancers but non-melanoma skin cancer
Laura D Attardi
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
All cancers but non-melanoma skin cancer
Dewi Harjanto
Does the RNA editor Apobec-1 shift microRNA targeting to a tumorigenic effect?
All cancers but non-melanoma skin cancer
Calvin J Kuo
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer Loci
Colorectum
Petra Hajkova
Reprogramming and Chromatin
All cancers but non-melanoma skin cancer